[Effect of a novel tyrosine kinase inhibitor HHGV678 on growth inhibition of Bcr-Abl wild type and IM-resistant cell lines in vitro].

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

Volumn 16, Issue 5, 2008, Pages 1039-1043

  Qiu, Lin ^a   Wang, Xiao Dan ^b   Yu, Bo Hai ^b   Lu, Ren Zhang ^b   Ge, Fang ^b   Wang, Xiu Li ^b   Chen, Li Jun ^b   Han, Bing Hong ^b   Zhan, Zhao Ming ^b   Zhang, Bo Long ^b   Ma, Jun ^b  

^a Harbin Institute of Hematolgy amp Oncology   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HHGV678; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; HUMAN; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; HUMANS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

EID: 77649183624     PISSN: 10092137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)